Cargando…

Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis

Detalles Bibliográficos
Autores principales:	Ameye, Heleen, Fransis, Sabine, Lerut, Evelyne, Metalidis, Christoph, Sprangers, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Nephrology Round
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678843/ https://www.ncbi.nlm.nih.gov/pubmed/29142922 http://dx.doi.org/10.1016/j.ekir.2016.06.004

Ejemplares similares

Pauci-Immune Crescentic Glomerulonephritis due to Disseminated Histoplasmosis
por: Said, Samar M., et al.
Publicado: (2019)

Pauci-immune Crescentic Glomerulonephritis Due to MGRS Crystalline Nephropathy
por: Sharma, Shailendra, et al.
Publicado: (2019)

Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab
por: Lemahieu, Wim, et al.
Publicado: (2018)

Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
por: Hui, Jessica W., et al.
Publicado: (2020)

Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2020)

A Case of Colon Cancer and Pauci-Immune Crescentic Glomerulonephritis
por: Wilhelm, David, et al.
Publicado: (2022)

Immune Check Point Inhibitor–Associated Glomerulonephritis
por: Ashour, Tarek, et al.
Publicado: (2018)

Immune-Complex Glomerulonephritis After COVID-19 Infection
por: Sethi, Sanjeev, et al.
Publicado: (2021)

Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
por: Chanchlani, Rahul, et al.
Publicado: (2017)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
por: Satoskar, Anjali A., et al.
Publicado: (2022)

Glomerulonephritis in Youth With Dystrophic Epidermolysis Bullosa
por: Hughley, Erica, et al.
Publicado: (2020)

Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition
por: Sethi, Sanjeev, et al.
Publicado: (2016)

Cancer-Associated AA Amyloidosis Presenting as Crescentic Glomerulonephritis
por: Zuckerman, Jonathan E., et al.
Publicado: (2019)

Familial Fibrillary Glomerulonephritis in Living Related Kidney Transplantation
por: Jeyabalan, Anushya, et al.
Publicado: (2020)

Cat-Scratch Disease Masquerading as C3 Glomerulonephritis
por: Sutu, Benjamin, et al.
Publicado: (2020)

Membranoproliferative Glomerulonephritis in a Patient With Chronic Q Fever
por: Leclerc, Simon, et al.
Publicado: (2020)

Avacopan in Patients With Rapidly Progressive Glomerulonephritis Requiring Dialysis
por: Cortazar, Frank B., et al.
Publicado: (2023)

Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy
por: Howlader, Anjuman, et al.
Publicado: (2017)

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020)

Rituximab for the Treatment of Pediatric Double-Positive Small-Vessel Vasculitis
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2019)

Natural Killer Cell Large Granular Lymphocyte Leukemia-Induced Glomerulonephritis
por: Isnard, Pierre, et al.
Publicado: (2021)

Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018)

Something Out of Nothing: A Rare Case of Pulmonary Renal Syndrome With Pauci-Immune Glomerulonephritis and Diffuse Alveolar Hemorrhage With Negative Serologies
por: Wang, Lucas Jiaxue, et al.
Publicado: (2021)

Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy
por: Sise, Meghan E., et al.
Publicado: (2016)

Glomerulonephritis With Isolated C3 Deposits as a Manifestation of Subtotal Factor I Deficiency
por: Boudhabhay, Idris, et al.
Publicado: (2019)

KM55 Monoclonal Antibody and IgA Variant of Proliferative Glomerulonephritis With Monoclonal Ig Deposits
por: Zhang, Minfang, et al.
Publicado: (2020)

Atypical Infection-Related Glomerulonephritis With “Masked” IgG-Kappa Crystalline Hump-Like Deposits
por: DiFranza, Lanny T., et al.
Publicado: (2020)

Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine
por: Dube, Geoffrey K., et al.
Publicado: (2021)

Autologous Stem Cell Transplant for the Treatment of Type I Crystal Cryoglobulinemic Glomerulonephritis Caused by Monoclonal Gammopathy of Renal Significance (MGRS)
por: Kousios, Andreas, et al.
Publicado: (2019)

IgA-Dominant Acute Postinfectious Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient
por: Anand, Manish, et al.
Publicado: (2017)

Persistent Hepatitis C Virus−Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy
por: Santoriello, Dominick, et al.
Publicado: (2018)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Diffuse Endocapillary Glomerulonephritis in a Child With IL-17RA Deficiency Emphasizes the Pivotal Role of the Complement Cascade and Anaphylatoxins
por: d’Izarny-Gargas, Thibaut, et al.
Publicado: (2023)

Two Cases of Proliferative Glomerulonephritis With Monoclonal IgG Deposits Treated With Renin Angiotensin Inhibition Alone With Long-term Follow-up
por: Rosenstock, Jordan L., et al.
Publicado: (2021)

Monoclonal Gammopathy of Renal Significance Causes C3 Glomerulonephritis Via Monoclonal IgG Kappa Inhibition of Complement Factor H
por: Johnson, Christopher K., et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)

Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab
por: Georges, Elodie, et al.
Publicado: (2019)

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
por: Ainley, Louise, et al.
Publicado: (2020)

Immune Check Point Inhibitor–Associated Endothelialitis
por: Bobart, Shane A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62cral6t1kvadrmbi493m6mho6